EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Immunometabolic Targets in CD8 + T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma

Yanze Lin, Rexiati Ruze, Ruiqing Zhang, Talaiti Tuergan, Maolin Wang, Alimu Tulahong, Dalong Zhu, Zhongdian Yuan, Tiemin Jiang, Tuerganaili Aji, Yingmei Shao

Liver Cancer · 21.11.2024 · 14 (4) · 474-496

DOI: 10.1159/000542578 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver Cancer, online erschienen am 21.11.2024. Verfasst von Yanze Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, the First Affiliated Hospital of Xinjiang Medical Univ…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: CD8+ T cells are critical for the oncogenesis and progression of the hepatocellular carcinoma (HCC) tumor microenvironment, receiving antigen signals from antigen-presenting cells and directly contributing to antitumor responses. Summary: CD8+ T cells mediate immunogenic cell death, facilitate immune signal transmission, and play a significant role in various treatments, including surgery, transarterial chemoembolization, and immunotherapy. Extensive research on the role of CD8+ T cells within the HCC microenvironment has shown considerable progress. Immunometabolic targets on CD8+ T cells have demonstrated potential in combination with immunotherapies for HCC; however, they have not yet reached the clinical trial stage. Key Messages: This review provides a comprehensive overview of recent research on immune and immunometabolic targets of CD8+ T cells within the HCC microenvironment. By highlighting advances and potential mechanisms, this review aims to support the development of effective clinical strategies in this field.

Schlagwörter

Stichwörter der Autor:innen

CD8+ T cellHepatocellular carcinomaImmunotherapyMammalian target of rapamycinMetabolismTumor microenvironment

Autor:innen und Institutionen

  • Department of Hepatobiliary and Echinococcosis Surgery, Digestive and Vascular Surgery Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, PR China.
  • Clinical Research Center for Echinococcosis and Hepatobiliary Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, PR China.
  • The First Clinical Medical College, Xinjiang Medical University, Urumqi, PR China.

Zitieren

APA

Lin, Y., Ruze, R., Zhang, R., Tuergan, T., Wang, M., Tulahong, A., Zhu, D., Yuan, Z., Jiang, T., Aji, T., & Shao, Y. (2024). Immunometabolic Targets in CD8 + T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma. Liver Cancer, 14(4), 474-496. https://doi.org/10.1159/000542578

Vancouver

Lin Y, Ruze R, Zhang R, Tuergan T, Wang M, Tulahong A, et al. Immunometabolic Targets in CD8 + T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma. Liver Cancer. 2024;14(4):474-496. doi:10.1159/000542578

BibTeX
@article{Lin2024,
  author = {Lin, Yanze and Ruze, Rexiati and Zhang, Ruiqing and Tuergan, Talaiti and Wang, Maolin and Tulahong, Alimu and Zhu, Dalong and Yuan, Zhongdian and Jiang, Tiemin and Aji, Tuerganaili and Shao, Yingmei},
  title = {Immunometabolic Targets in CD8 + T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma},
  journal = {Liver Cancer},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {474--496},
  doi = {10.1159/000542578}
}
Kostenlos starten →